A.W. Griffioen

Discipline

Histoire, Philosophie et Sociologie des sciences (2)

Type de document

Articles (10) Recensions (2)

Co-auteur

Date

Source

Mot-clé

Treatment (9) Cancer (8) thérapie (6) cancer (6) Cancer (6) Therapeutics (6) Number (6) Neovascularization (5) Inhibition (5) Cells (5) Endothelial cells (5) Development (4) Drugs (4) Agent (Philosophy) (4) modèle (3) membrane (3) analyse (3) abords (agglomération) (3) Human beings (3) Example (3) Combinations (3) Cell lines (3) Blood (3) Bevacizumab (3) Analysis (3) Side effects (3) Models (3) puits (2) toxicité (2) tissu (corporel) (2)

Documents écrit par A.W. Griffioen (10) | parle de A.W. Griffioen (0)

Characterization of Renal Cell Carcinoma Heterotypic 3D Co-Cultures with Immune Cell Subsets.
M. Rausch et al. (22 mai 2021)
Angiogenesis in gynecological cancers and the options for anti-angiogenesis therapy.
B. Yetkin-Arik et al.
Optimized low-dose combinatorial drug treatment boosts selectivity and efficacy of colorectal carcinoma treatment.
M. Zoetemelk et al.
Integrating Phenotypic Search and Phosphoproteomic Profiling of Active Kinases for Optimization of Drug Mixtures for RCC Treatment.
J.R. van Beijnum et al. (21 sept. 2020)
IGF2 and IGF1R identified as novel tip cell genes in primary microvascular endothelial cell monolayers.
M.G. Dallinga et al.
Consensus guidelines for the use and interpretation of angiogenesis assays.
P. Nowak-Sliwinska et al.
Rapid optimization of drug combinations for the optimal angiostatic treatment of cancer.
A. Weiss et al. (2015)
Low-dose angiostatic tyrosine kinase inhibitors improve photodynamic therapy for cancer: lack of vascular normalization.
A. Weiss et al. (2014)
Synthesis and characterization of a new class of anti-angiogenic agents based on ruthenium clusters.
A.A. Nazarov et al. (2013)
Angiostatic kinase inhibitors to sustain photodynamic angio-occlusion.
P. Nowak-Sliwinska et al. (2012)